GLP-1 Medication Supplier
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract agreement with the City of Cambridge involves the supply of GLP-1 receptor agonist medications, such as Semaglutide or Liraglutide, for prime contractors on healthcare projects. The supplier is responsible for providing pharmaceutical-grade medications and utilizing specialized cold-chain storage and transport equipment to maintain product stability during delivery to designated addresses. To qualify, the provider must hold all necessary Pharmaceutical Wholesale and Distribution Licenses, maintain FDA compliance, and be licensed within the State of Massachusetts. This opportunity is categorized under NAICS code 424210, with a response deadline of October 15, 2026, for performance within Cambridge, Massachusetts.
General Info
Place of Performance
Cambridge, MA, 02139, USASet-Aside
Documents
This scope was carved out of BD-27-1144-CAMBR-CAMBR-133820.
The full solicitation package (3 documents), including the RFP, is on the prime solicitation, not on this scope.
#31207 RFP For GLP-1 Medication Access, Affordability & Management Solutions
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Massachusetts → CAMBR - City of Cambridge
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
